Archived Content

The content on this page is provided for reference purposes only. This content has not been altered or updated since it was archived.

Vaccines, Blood & Biologics

Division of Manufacturing and Product Quality (DMPQ)

The Division of Manufacturing and Product Quality (DMPQ) within OCBQ has many responsibilities, including the following:

  • Manages the overall program responsibilities for the Division, primarily lot release, review of application-based submissions, and inspections.
  • Reviews, evaluates, and takes appropriate action on Investigational New Drug applications (INDs), marketing applications, supplements, and amendments submitted to CBER, as part of the managed review process. Performs Chemistry, Manufacturing, and Controls (CMC) and Current Good Manufacturing Practice (CGMP) reviews for specific CBER-regulated products.
  • Performs quality assurance review of completed submissions for consistency in technical content as well as administrative process requirements.

Product Release Branch

Major responsibilities of the Product Release Branch include:

  • Develops and administers the biological products lot release program, in coordination with other CBER components.
  • Reviews manufacturers' submissions for licensed biological product lots.
  • Receives, maintains, and distributes samples of biological products submitted for testing.
  • Provides the final quality review for lot release submissions and prepares release correspondence for company notifications.

The Product Release Branch recommends the following resources for manufacturers.

Manufacturing and Review Branches 1 and 2

Major responsibilities of the Manufacturing and Review Branch 1 and Branch 2 include:

  • Reviews, evaluates, and takes appropriate action on INDs, marketing applications, supplements, and amendments submitted to CBER) as part of the managed review process. Performs CMC and CGMP reviews.
  • Meets with manufacturers to review facility design/CGMP/new products and technologies.
  • Leads prelicense and preapproval inspections supporting Biologics License Application submissions and supplements, as part of the CBER managed review process. Prepares inspection reports as part of an inspection team and evaluates firms’ corrective actions.

The Manufacturing and Review Branches recommend the following resources for manufacturers.

Applications Review Branch

Major responsibilities of the Applications Branch include:

  • Prepares review packages and correspondence for final action on supplements. Schedules and coordinates meetings with industry as well as finalizes meeting minutes for distribution.
  • Performs all data entry for assignment and tracking of submissions and also generates work load reports in order to maintain operations within the designated PDUFA and MDUFMA time frames.
  • Issues and reissues U.S. and biologics licenses.

Additional Information about DMPQ

Additional information about DMPQ's responsibilities is available in FDA’s Staff Manual Guide.

Contact FDA

(800) 835-4709
(240) 402-8010
Consumer Affairs Branch (CBER)

Division of Communication and Consumer Affairs

Office of Communication, Outreach and Development

Food and Drug Administration

10903 New Hampshire Avenue

Building 71 Room 3103

Silver Spring, MD 20993-0002

Page Last Updated: 01/26/2015
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.